Gravar-mail: GENE-16. EVALUATING THE UTILITY OF INTEGRATED CLINICAL SEQUENCING FOR CHILDHOOD NEURO-ONCOLOGY PATIENTS: THE TEXAS KIDSCANSEQ STUDY